Sucroferric Oxyhydroxide (SO) is a non-calcium, iron-based, chewable phosphate binder indicated for the control of serum phosphorus levels in patients with end-stage renal disease (ESRD) receiving dialysis. There is minimal systemic iron absorption from sucroferric oxyhydroxide, and therefore the drug is associated with a low risk of iron accumulation.
Sucroferric oxyhydroxide is a non-absorbable phosphate binder synthesized via controlled hydrolysis of ferric salts with sucrose. Its chemical formula is FeO(OH)·C12H22O11, and it carries CAS No. 10598-48-6.
Contraindicated in patients with iron overload disorders. Store in a dry place below 25°C to prevent hygroscopic clumping. Avoid inhalation of dust during handling; use appropriate respiratory protection.